Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-05 Sale |
2025-03-06 7:22 pm |
Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN Chief Commercial Officer, MRD |
26,023 | $6.98 | $181,641 | 527,267 (Direct) |
View |
| 2024-03-05 Sale |
2024-03-06 7:39 pm |
Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN Chief Commercial Officer, MRD |
12,991 | $3.4354 | $44,629 | 447,839 (Direct) |
View |
| 2020-12-10 Sale |
2020-12-11 9:00 pm |
Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ |
25,000 | $55 | $1,375,000 | 30,000 (Direct) |
View |
| 2020-09-29 Sale |
2020-10-01 8:00 pm |
Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ |
10,000 | $50 | $500,000 | 55,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-04 Option Award |
2025-03-06 7:22 pm |
N/A 2035-03-04 |
Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN Chief Commercial Officer, MRD |
300,000 | $0 | 527,267 (Direct) |
View |
| 2024-10-08 Exercise |
2024-10-10 5:47 pm |
N/A 2024-10-13 |
Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN Chief Commercial Officer, MRD |
5,000 | $0 | 253,290 (Direct) |
View |
| 2024-10-08 Exercise |
2024-10-10 5:47 pm |
N/A N/A |
Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN Chief Commercial Officer, MRD |
5,000 | $1.98 | 253,290 (Direct) |
View |
| 2024-03-04 Option Award |
2024-03-06 7:39 pm |
N/A 2034-03-04 |
Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN Chief Commercial Officer, MRD |
332,528 | $0 | 447,839 (Direct) |
View |
Ownership |
2024-03-06 7:38 pm |
N/A N/A |
Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN Chief Commercial Officer, MRD |
0 | $0 | 430,074 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-08 7:00 pm |
N/A 2021-03-04 |
Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ |
32,052 | $0 | 32,052 (Direct) |
View |
| 2020-12-10 Exercise |
2020-12-11 9:00 pm |
N/A 2024-10-13 |
Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ |
25,000 | $0 | 30,000 (Direct) |
View |
| 2020-12-10 Exercise |
2020-12-11 9:00 pm |
N/A N/A |
Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ |
25,000 | $1.98 | 30,000 (Direct) |
View |
| 2020-09-29 Exercise |
2020-10-01 8:00 pm |
N/A 2024-10-13 |
Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ |
10,000 | $0 | 55,000 (Direct) |
View |
| 2020-09-29 Exercise |
2020-10-01 8:00 pm |
N/A N/A |
Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ |
10,000 | $1.98 | 55,000 (Direct) |
View |
Ownership |
2020-08-14 9:00 pm |
N/A 2024-10-13 |
Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ |
0 | $0 | 127,224 (Direct) |
View |
| 2020-08-13 Option Award |
2020-08-14 9:00 pm |
N/A 2030-08-13 |
Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ |
20,000 | $0 | 20,000 (Direct) |
View |